Atorvastatin use in specific populations: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Atorvastatin}} | {{Atorvastatin}} | ||
{{CMG}}; {{AE}} {{PB}} | {{CMG}}; {{AE}} {{PB}} | ||
[[Hepatic impairment]]: Plasma concentrations markedly increased in patients with chronic [[alcoholic liver disease]]. | [[Hepatic impairment]]: Plasma concentrations markedly increased in patients with chronic [[alcoholic liver disease]]. | ||
Revision as of 15:04, 30 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Hepatic impairment: Plasma concentrations markedly increased in patients with chronic alcoholic liver disease.